1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow IgA Vasculitis: new trials by email Literature Review of IgA Vasculitis trials Research Report on IgA Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy? Oral prednisolone and SoC, Gut-directed budesonide and SoC, Mycophenolate mofetil (MMF) and SoC - IgA Nephropathy, Renal Insufficiency, Chronic | Phase 4 | Recruiting | Christian Medical College, Vellore, India | 585 | 2025-02-15 | 2025-07-14 |
| HSP-glomerulonephritis Trial: MP vs CyA Methylprednisolone pulses plus prednisone versus Cyclosporine A - Purpura, Schoenlein-Henoch | Phase 4 | Completed | Oulu University Hospital | 20 | 2000-01-01 | 2011-08-08 |
Glomerulonephritis (2) · Glomerulonephritis, IGA (1) · Nephritis (1) · Nephrotic Syndrome (1) · Proteinuria (1) · Renal Insufficiency, Chronic (1)
Blood Coagulation Disorders (2) · Cardiovascular Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhage (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Hypersensitivity (2) · Immune Complex Diseases (2) · Immune System Diseases (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Pathologic Processes (2)
Angiotensin Receptor Antagonists (1) · Hydroxychloroquine (1) · Mycophenolic Acid (1) · Prednisolone (1)
Christian Medical College, Vellore, India (1) · Oulu University Hospital (1)
Finland (1) · India (1)
George T John, DM, FRCP, FRACP (1) · Jonathan Barratt, PhD, FRCP (1) · Matti Nuutinen, M.D., Ph.D. (1)